• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Drug Abuse Testing Market Trends

    ID: MRFR/Pharma/1398-CR
    92 Pages
    Rahul Gotadki
    July 2025

    Drug of Abuse Testing Market Research Report By Test Type (Urine Testing, Blood Testing, Saliva Testing, Hair Testing), By Methodology (Immunoassays, Chromatography, Spectrometry), By End Use (Hospitals, Laboratories, Workplaces, Home Care), By Substance Tested (Cannabis, Cocaine, Opiates, Amphetamines, Phencyclidine) and By Regional (North America, Europe, South America, Asia Pacific, Middle E...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Drug Abuse Testing Market Infographic
    Purchase Options

    Market Trends

    Key Emerging Trends in the Drug Abuse Testing Market

    The drug abuse testing business is evolving as substance abuse detection evolves and individuals desire more accurate and decisive tests. Drug testing is increasingly using modern technology. Oral fluid, hair, and sweat tests enhance urine-based testing by expanding detection window and sensitivity. This tendency necessitates more stringent testing procedures that can identify more substances and provide a more accurate drug history. A further trend is the development of point-of-care (POC) drug testing solutions. POC testing enables immediate results delivered through rapid on-site screening, enhancing timely interventions as well as reducing turnaround time for decision making. In various settings such as workplaces, healthcare providers, law enforcement agencies etc., there is an increasing desire to have faster and easier access to drug-testing services. Additionally, advancements have been made in synthetic drugs and designer drugs’ detection in the drug of abuse testing market. The occurrence of new psychoactive substances defies conventional drug screening approaches. Advanced analytical techniques such as liquid chromatography or mass spectrometry are being integrated into laboratories for accurate identification and detection of these synthetic drugs. This trend points out the need for current test methodologies capable to keep up with new chemicals emerging in illegal drug markets. Furthermore, digital technologies are increasingly becoming part of the process in drug abuse testing. Result reporting, data management as well as communication among those involved in the exercise is done using digital platforms or mobile applications only. This leads towards automation hence streamlining the process while increasing efficiency besides ensuring test results remain confidential and secure.

    Another major trend has been identified regarding workplace-based substance abuse programs. Employers nowadays recognize how substance abuse affects workplace safety & productivity thus resulting to adoption comprehensive drug-testing initiatives at their places of work such that pre-employment, random or post incident testing exists thereby creating safer and more secure environments. This trend demonstrates the importance of substance abuse prevention at workplaces.

    Additionally, drug abuse testing panels are becoming more inclusive. Traditional testing targeted opioids, marijuana, cocaine, and amphetamines. However, screening should include prescription medications, synthetic opioids, and new drugs of abuse. This move reflects evolving drug misuse tendencies and the necessity for extensive testing to prevent illicit and prescribed medicine use.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What was the expected market size of the Drug of Abuse Testing Market in 2024?

    The Drug of Abuse Testing Market was valued at 4.92 USD Billion in 2024.

    What is the projected value of the Drug of Abuse Testing Market by 2035?

    The market is expected to reach a valuation of 8.2 USD Billion by 2035.

    What is the expected CAGR for the Drug of Abuse Testing Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 4.75% from 2025 to 2035.

    Which region held the largest market share in 2024?

    North America have the largest market share valued at 2.15 USD Billion in 2024.

    What will be the market size of the North American region by 2035?

    The North American market is projected to be valued at 3.48 USD Billion by 2035.

    What was the expected market value for Urine Testing in 2024?

    Urine Testing was valued at 2.0 USD Billion in 2024.

    How much will the Blood Testing segment be valued in 2035?

    The Blood Testing segment is expected to reach 2.0 USD Billion in 2035.

    Who are the key players in the Drug of Abuse Testing Market?

    Major players include F. HoffmannLa Roche, Quest Diagnostics, and Thermo Fisher Scientific, among others,

    What was the estimated market size for Saliva Testing in 2024?

    The Saliva Testing segment was valued at 0.9 USD Billion in 2024.

    What challenges might the Drug of Abuse Testing Market face in the coming years?

    Challenges may include regulatory hurdles and competition among key players in the market.

    Market Summary

    As per Market Research Future Analysis, the Drug of Abuse Testing Market was valued at 4.7 USD Billion in 2023 and is projected to grow to 8.2 USD Billion by 2035, reflecting a CAGR of 4.75% from 2025 to 2035. The market is driven by increasing drug abuse incidences and stringent regulatory guidelines mandating drug testing across various sectors.

    Key Market Trends & Highlights

    The Drug of Abuse Testing Market is witnessing significant trends influenced by regulatory changes and technological advancements.

    • The market is expected to grow from 4.92 USD Billion in 2024 to 8.2 USD Billion by 2035.
    • Urine Testing is the dominant method, projected to increase from 2.0 USD Billion in 2024 to 3.3 USD Billion by 2035.
    • North America leads the market with a valuation of 2.12 USD Billion in 2024, expected to reach 3.54 USD Billion by 2035.
    • Technological advancements, including point-of-care testing, are enhancing testing accuracy and efficiency.

    Market Size & Forecast

    2023 Market Size USD 4.7 Billion
    2024 Market Size USD 4.92 Billion
    2035 Market Size USD 8.2 Billion
    CAGR (2025-2035) 4.75%
    Largest Regional Market Share in 2024 North America

    Major Players

    Key companies include Roche Holdings, Alere, Abbott Laboratories, Quest Diagnostics, and Thermo Fisher Scientific.

    Market Trends

    The Drug of Abuse Testing Market is undergoing a number of significant trends that are being driven by the growing awareness and initiatives aimed at drug prevention and detection. In a variety of sectors, including healthcare, law enforcement, and workplace safety, governments worldwide are emphasizing the significance of drug testing. This requirement is being driven by the implementation of programs by a variety of health departments, particularly in response to the increasing prevalence of substance misuse. 

    Enhanced regulations concerning drug testing in schools and workplaces are intended to foster safer environments, which in turn encourages the adoption of testing solutions. Advancements in testing technologies are generating opportunities for market expansion in the Drug of Abuse Testing Market. The efficiency and accuracy of innovative methods, such as lab-on-a-chip technologies and rapid testing devices, are causing them to acquire popularity. The transition to at-home testing solutions offers supplementary opportunities, as individuals prioritize convenience and privacy.

    Additionally, the growing prevalence of synthetic drugs is driving a need for sophisticated testing methods that can accurately identify a broader spectrum of substances. Point-of-care testing is becoming increasingly popular due to its rapid results and user-friendliness, as evidenced by recent trends. The integration of digital platforms and mobile technology for the management of testing reports is also on the rise as companies and laboratories strive to optimize their operations.

    In general, the emphasis on improving user experience, adhering to safety regulations, and adapting to new drug variants is indicative of the market's dynamic nature and the significance of anticipating emergent challenges and opportunities in the global arena.

    The increasing prevalence of substance abuse and the growing emphasis on workplace safety are driving the demand for drug testing solutions across various sectors.

    Substance Abuse and Mental Health Services Administration (SAMHSA)

    Drug Abuse Testing Market Market Drivers

    Market Trends and Projections

    The Global Drug of Abuse Testing Market Industry is poised for substantial growth, with projections indicating a market value of 8.2 USD Billion by 2035. The compound annual growth rate of 4.75% from 2025 to 2035 suggests a steady increase in demand for drug testing solutions. This growth is driven by various factors, including rising substance abuse rates, regulatory compliance, and technological advancements. As organizations and governments prioritize drug testing initiatives, the market is likely to expand, reflecting the ongoing commitment to addressing drug abuse challenges globally. The evolving landscape of drug testing will continue to shape the industry in the coming years.

    Increasing Substance Abuse Rates

    The Global Drug of Abuse Testing Market Industry is experiencing growth due to rising substance abuse rates worldwide. Reports indicate that drug use has escalated, particularly among young adults, leading to a heightened demand for testing solutions. In 2024, the market is valued at 4.92 USD Billion, reflecting the urgent need for effective drug testing methods. Governments and organizations are increasingly investing in drug testing programs to combat this issue, which is expected to drive market expansion. The prevalence of opioid use, for instance, has prompted regulatory bodies to implement stricter testing protocols, thereby influencing the market positively.

    Regulatory Compliance and Workplace Safety

    Regulatory compliance is a crucial driver for the Global Drug of Abuse Testing Market Industry. Many countries have established stringent regulations mandating drug testing in workplaces, particularly in safety-sensitive industries such as transportation and construction. This regulatory landscape compels employers to adopt comprehensive drug testing programs to ensure a safe working environment. As a result, the market is projected to grow, with an expected value of 8.2 USD Billion by 2035. Companies are increasingly recognizing the importance of maintaining compliance to avoid legal repercussions and enhance employee safety, further propelling the demand for drug testing solutions.

    Growing Awareness of Drug Abuse Consequences

    The growing awareness of the consequences of drug abuse is driving the Global Drug of Abuse Testing Market Industry. Educational campaigns and community outreach programs are increasingly highlighting the risks associated with substance abuse, leading to a greater demand for drug testing solutions. As individuals and organizations become more informed about the potential impacts of drug use, the need for effective testing methods rises. This heightened awareness is likely to result in increased investments in drug testing programs across various sectors, further stimulating market growth. The proactive approach to addressing drug abuse is expected to play a pivotal role in shaping the future of the market.

    Technological Advancements in Testing Methods

    Technological advancements are significantly influencing the Global Drug of Abuse Testing Market Industry. Innovations in testing methods, such as the development of rapid testing kits and advanced laboratory techniques, are enhancing the accuracy and efficiency of drug testing. These advancements not only reduce the time required for results but also improve the reliability of testing outcomes. As organizations seek to implement more effective drug testing programs, the adoption of these technologies is expected to rise. This trend is likely to contribute to a compound annual growth rate of 4.75% from 2025 to 2035, reflecting the market's adaptability to evolving testing needs.

    Market Segment Insights

    Drug of Abuse Testing Market Test Type Insights

    The Drug of Abuse Testing Market reveals a diverse landscape characterized by various test types, each catering to unique requirements in detecting substance misuse. In 2024, the market for drug testing was valued at approximately 4.92 USD Billion and is set to grow significantly, showcasing dynamic trends influenced by regulatory frameworks, increasing awareness of drug abuse consequences, and technological advancements.

    The segment constituting Urine Testing holds a substantial share, valued at 2.0 USD Billion in 2024 and anticipated to grow to 3.3 USD Billion by 2035, highlighting its major role in the market due to its convenience, cost-effectiveness, and quick results.Blood Testing, valued at 1.2 USD Billion in 2024, is crucial because it provides precise quantification of substances in the system, thus gaining traction in clinical settings. Saliva Testing, carrying a valuation of 0.9 USD Billion in the same year, is gaining popularity owing to its non-invasive nature and ease of administration, making it an attractive option for on-site testing.

    Furthermore, Hair Testing, represented with a value of 0.82 USD Billion in 2024, offers a longer detection window, catering to specialized industry needs, although it occupies a smaller segment of the market.The collective growth across these test types is propelled by the increasing demand for drug screening in workplaces, sporting events, and legal settings, alongside growing awareness concerning health risks associated with drug abuse.

    While Urine Testing continues to dominate due to its majority holding, the other test types reflect significant potential driven by their specificity, reliability, and emerging trends, contributing to the overall growth and diversification of the Drug of Abuse Testing Market.

    Drug of Abuse Testing Market Methodology Insights

    The Drug of Abuse Testing Market has shown steady growth, with the overall market reached 4.92 USD Billion in 2024. This market is segmented based on Methodology, including techniques such as Immunoassays, Chromatography, and Spectrometry. Immunoassays are widely utilized due to their efficiency and rapid results in initial drug screening processes, making them a dominant choice in various testing environments. Chromatography techniques provide high accuracy and are essential for confirmatory testing, ensuring reliability in drug detection.Spectrometry, with its advanced detection capabilities, complements these methodologies by enabling precise quantification of substances.

    The collective effectiveness of these methodologies supports the increased adoption of drug testing across healthcare, law enforcement, and workplace environments. Market growth is driven by factors such as stringent regulations regarding drug abuse and rising awareness about substance abuse. However, challenges remain, including technological integrity and the need for continual advancements to keep pace with emerging substances.These methodologies play a crucial role in addressing these market dynamics while supporting the growing demand within the Drug of Abuse Testing Market.

    Drug of Abuse Testing Market End Use Insights

    The Drug of Abuse Testing Market, valued at 4.92 USD Billion in 2024, displays noteworthy segmentation, particularly within the End Use category. This category comprises various formats, including Hospitals, Laboratories, Workplaces, and Home Care. Hospitals play a crucial role, as they conduct most drug testing, ensuring patient safety and managing substance-related emergencies. Laboratories contribute with specialized testing techniques that enhance accuracy and reliability, enabling effective drug monitoring and compliance.

    Workplaces increasingly implement drug testing programs as part of their employee wellness initiatives, driven by the need for a safe working environment and the reduction of liability.Home Care is gaining traction, reflecting a shift towards personal health management and the flexibility of at-home testing solutions. The emphasis on drug testing across these segments is influenced by rising drug abuse concerns, changing legislation, and the need for improved public health strategies.

    As such, the Drug of Abuse Testing Market segmentation demonstrates varied yet interconnected growth drivers and significant opportunities, particularly in enhancing methodologies and expanding access to testing services across all end-use areas.

    Drug of Abuse Testing Market Substance Tested Insights

    The Drug of Abuse Testing Market, particularly focusing on the Substance Tested segment, has been experiencing notable growth. The market reached a valuation of 4.92 USD Billion in 2024, with cannabis, cocaine, opiates, amphetamines, and phencyclidine as key substances of interest. Each of these substances plays a critical role in the overall market dynamics, with cannabis testing becoming increasingly prominent due to its legalization across various regions, thus expanding the need for effective testing methods.

    Cocaine remains a significant concern due to its widespread recreational use, necessitating robust testing protocols.Opiates, linked to the ongoing opioid crisis, demand stringent testing to monitor and manage abuse. Amphetamines are frequently detected in both clinical and workplace settings, while phencyclidine, though less common, requires specialized testing approaches. The trends indicate a continuous increase in testing across these substances, driven by growing awareness, regulatory frameworks, and the need for safety in workplaces, healthcare, and criminal justice settings.

    As the Drug of Abuse Testing Market collects more data, it enables stakeholders to better understand substance use patterns and inform public health strategies, reflecting the diverse challenges and opportunities within this domain.

    Get more detailed insights about Drug of Abuse Testing Market Research Report - Forecast till 2035

    Regional Insights

    The Drug of Abuse Testing Market is witnessing significant growth across various regions, with a projected value of 4.92 USD Billion in 2024. North America holds the largest share, valued at 2.15 USD Billion, and is expected to rise to 3.48 USD Billion by 2035, showcasing its dominant position in this market due to stringent regulations and a high prevalence of drug abuse issues.

    Europe follows as the second-largest market, valued at 1.25 USD Billion in 2024 and expected to reach 2.06 USD Billion, driven by increased awareness and government initiatives focused on drug testing.South America, while smaller at 0.45 USD Billion in 2024, is important as emerging economies are beginning to implement drug testing regulations, projected to grow to 0.78 USD Billion. The Asia Pacific region, valued at 0.95 USD Billion, emphasizes a growing understanding of drug abuse challenges and is expected to expand to 1.57 USD Billion.

    Lastly, the Middle East and Africa market, valued at 0.12 USD Billion, is slower to grow, largely due to varying regulatory environments and cultural attitudes towards drug testing, projected to reach 0.21 USD Billion.Overall, this regional segmentation of the Drug of Abuse Testing Market illustrates significant growth potential and varying dynamics influenced by local regulations, awareness, and market drivers.

    Drug of Abuse Testing Market Regional Insights

    Key Players and Competitive Insights

    The Drug of Abuse Testing Market is characterized by a diverse range of players who develop and offer innovative testing solutions to address the critical need for reliable drug testing methods across various sectors, including healthcare, workplace, and law enforcement. This market is driven by rising concerns regarding substance abuse and its impact on public health and safety. The competitive landscape features both well-established enterprises and emerging companies, each vying for market share through advancements in technology, product differentiation, and strategic partnerships.

    Trends such as increased adoption of point-of-care testing, regulatory compliance, and the integration of digital technologies into the testing process are shaping the market dynamics. Companies that effectively leverage these trends while responding to the unique demands of different regions are positioned to gain a competitive edge.F. HoffmannLa Roche has established itself as a prominent player in the Drug of Abuse Testing Market, recognized for its strong emphasis on research and development, coupled with its commitment to high-quality standards. The company has a robust portfolio of drug testing products, which includes sophisticated immunoassay tests and molecular diagnostic solutions.

    Its expertise in pharmaceuticals and diagnostics enables F. HoffmannLa Roche to develop comprehensive testing methodologies that cater to various applications such as clinical laboratories and toxicology screenings. The organization’s global presence further strengthens its market position, allowing it to distribute its innovative products and services across a wide range of geographical markets.

    The company's investment in cutting-edge technology and a deep understanding of regulatory processes contribute significantly to its strengths in maintaining a competitive advantage in the drug testing arena.Sonic Healthcare is a key entity within the Drug of Abuse Testing Market, known for its extensive laboratory services and commitment to quality and accuracy in test results. The company excels in providing a broad array of services, including drug and alcohol testing, tailored to meet the needs of both private and public sectors on a global scale.

    Sonic Healthcare stands out due to its streamlined operations, advanced laboratory capabilities, and a strong focus on customer service, which collectively enhance its market presence. The company’s global reach is augmented by strategic mergers and acquisitions that allow it to expand its service offerings and enhance its technological infrastructure. Key products/services offered by Sonic Healthcare are designed to ensure fast turnaround times for results, and this efficiency is particularly valued in the workplace and legal environments. Their commitment to continuous improvement and adaptation in testing methodologies helps solidify their position as a leading provider in the global arena.

    Key Companies in the Drug Abuse Testing Market market include

    Industry Developments

    Recent developments in the Drug of Abuse Testing Market indicate a growing emphasis on innovation and expansion among leading players. In mid-2024, Premier Biotech expanded its testing portfolio by acquiring Desert Tox, a SAMHSA-certified laboratory, thereby improving its clinical and forensic capabilities. An comprehensive 88-compound NPS urine panel was introduced by Quest Diagnostics in late 2023 to enhance the detection of emergent synthetic drugs. 

    Thermo Fisher introduced a mass spectrometry-based platform with high sensitivity in November 2023, which enhanced the speed and precision of forensic and clinical examinations. With the integration of AI and mobile/cloud-based data systems to improve accuracy and accessibility, the broader industry is continuing to transition to point-of-care and non-invasive testing formats, including saliva, hair, and perspiration. 

    Geographically, North America maintains its leadership in terms of regulatory frameworks, while Asia-Pacific is the leader in terms of growth as a result of the increasing awareness of substance use and rise in workplace safety mandates. In general, the global market was valued at approximately US$6.7 billion between 2022 and 2023. It is anticipated that this figure will nearly double by 2032, with a robust 5–7% compound annual growth rate.

    Future Outlook

    Drug Abuse Testing Market Future Outlook

    The Drug of Abuse Testing Market is projected to grow at a 4.75% CAGR from 2024 to 2035, driven by technological advancements, regulatory changes, and increasing awareness of substance abuse.

    New opportunities lie in:

    • Developing rapid testing kits for on-site drug screening in workplaces.
    • Leveraging AI for enhanced data analysis in drug testing processes.
    • Expanding testing services to include emerging synthetic drugs and designer substances.

    By 2035, the market is expected to demonstrate robust growth, reflecting heightened demand for innovative testing solutions.

    Market Segmentation

    Drug of Abuse Testing Market End Use Outlook

    • Hospitals
    • Laboratories
    • Workplaces
    • Home Care

    Drug of Abuse Testing Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Drug of Abuse Testing Market Test Type Outlook

    • Urine Testing
    • Blood Testing
    • Saliva Testing
    • Hair Testing

    Drug of Abuse Testing Market Methodology Outlook

    • Immunoassays
    • Chromatography
    • Spectrometry

    Drug of Abuse Testing Market Substance Tested Outlook

    • Cannabis
    • Cocaine
    • Opiates
    • Amphetamines
    • Phencyclidine

    Report Scope

    Report Attribute/Metric

    Details

    Market Size 2023

    4.7 (USD Billion)

    Market Size 2024

    4.92 (USD Billion)

    Market Size 2035

    8.2 (USD Billion)

    Compound Annual Growth Rate (CAGR)

    4.75% (2025 - 2035)

    Report Coverage

    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

    Base Year

    2024

    Market Forecast Period

    2025 - 2035

    Historical Data

    2019 - 2024

    Market Forecast Units

    USD Billion

    Key Companies Profiled

    F. HoffmannLa Roche, Sonic Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Henkel AG & Co KGaA, Siemens Healthineers, Dragerwerk AG, Laboratory Corporation of America, Psychiatric Solutions, RCM Life Sciences, NMS Labs, BD (Becton, Dickinson and Company), Alere Inc, Abbott Laboratories

    Segments Covered

    Test Type, Methodology, End Use, Substance Tested, Regional

    Key Market Opportunities

    Rising demand for personalized testing, Expansion of workplace testing programs, Increasing prevalence of substance abuse, Advancements in rapid testing technologies, Growth in telehealth drug testing services

    Key Market Dynamics

    rising substance abuse rates, technological advancements in testing, regulatory changes and compliance, increasing awareness of drug testing, growing demand in workplaces

    Countries Covered

    North America, Europe, APAC, South America, MEA

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What was the expected market size of the Drug of Abuse Testing Market in 2024?

    The Drug of Abuse Testing Market was valued at 4.92 USD Billion in 2024.

    What is the projected value of the Drug of Abuse Testing Market by 2035?

    The market is expected to reach a valuation of 8.2 USD Billion by 2035.

    What is the expected CAGR for the Drug of Abuse Testing Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 4.75% from 2025 to 2035.

    Which region held the largest market share in 2024?

    North America have the largest market share valued at 2.15 USD Billion in 2024.

    What will be the market size of the North American region by 2035?

    The North American market is projected to be valued at 3.48 USD Billion by 2035.

    What was the expected market value for Urine Testing in 2024?

    Urine Testing was valued at 2.0 USD Billion in 2024.

    How much will the Blood Testing segment be valued in 2035?

    The Blood Testing segment is expected to reach 2.0 USD Billion in 2035.

    Who are the key players in the Drug of Abuse Testing Market?

    Major players include F. HoffmannLa Roche, Quest Diagnostics, and Thermo Fisher Scientific, among others,

    What was the estimated market size for Saliva Testing in 2024?

    The Saliva Testing segment was valued at 0.9 USD Billion in 2024.

    What challenges might the Drug of Abuse Testing Market face in the coming years?

    Challenges may include regulatory hurdles and competition among key players in the market.

    1. EXECUTIVE SUMMARY
      1. 1.1.
      2. Market Overview
      3. Key Findings
      4. Market Segmentation
      5. 1.4.
      6. Competitive Landscape
      7. Challenges and Opportunities
      8. Future
      9. Outlook
      10. \r\n
    2. MARKET INTRODUCTION
      1. Definition
        1. Research Objective
        2. Assumption
      2. 2.2.
      3. Scope of the study
      4. 2.2.3.
      5. Limitations
    3. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
        1. Primary Interviews
        2. Breakdown of Primary Respondents
      5. and Information Gathering Process
      6. Forecasting Model
      7. Market Size Estimation
        1. Bottom-Up
        2. Top-Down Approach
      8. Approach
      9. Data Triangulation
      10. 3.8.
      11. Validation
      12. \r\n
    4. MARKET DYNAMICS
      1. Overview
      2. 4.2.
      3. Drivers
      4. Restraints
      5. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
        1. Bargaining Power of Buyers
        2. Threat of Substitutes
        3. Intensity
      3. 5.2.1.
      4. Bargaining Power of Suppliers
      5. 5.2.3.
      6. Threat of New Entrants
      7. of Rivalry
      8. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Regional Impact
        3. Opportunity and Threat Analysis
      9. \r\n
    6. DRUG OF ABUSE TESTING MARKET, BY TEST TYPE (USD BILLION)
      1. Urine
      2. Testing
      3. Blood Testing
      4. Saliva Testing
      5. Hair Testing
    7. DRUG OF ABUSE TESTING MARKET, BY METHODOLOGY (USD BILLION)
      1. Immunoassays
      2. Chromatography
      3. Spectrometry
    8. DRUG OF ABUSE TESTING
    9. MARKET, BY END USE (USD BILLION)
      1. Hospitals
      2. Laboratories
      3. Workplaces
      4. Home Care
    10. DRUG OF ABUSE TESTING MARKET, BY
      1. SUBSTANCE TESTED (USD BILLION)
      2. Cannabis
      3. Cocaine
      4. 9.3.
      5. Opiates
      6. Amphetamines
      7. Phencyclidine
    11. DRUG OF ABUSE
    12. TESTING MARKET, BY REGIONAL (USD BILLION)
      1. North America
        1. Canada
      2. 10.1.1.
      3. US
      4. Europe
        1. Germany
        2. UK
        3. France
        4. Russia
        5. Italy
        6. Spain
        7. Rest of Europe
      5. APAC
        1. China
        2. Japan
        3. South Korea
        4. Malaysia
        5. Indonesia
        6. Rest of APAC
      6. 10.3.2.
      7. India
      8. 10.3.6.
      9. Thailand
      10. South America
        1. Brazil
        2. Mexico
        3. Argentina
      11. 10.4.4.
      12. Rest of South America
      13. MEA
        1. GCC Countries
        2. Rest of MEA
      14. 10.5.2.
      15. South Africa
      16. \r\n
    13. COMPETITIVE LANDSCAPE
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Drug of Abuse Testing Market
      5. 11.5.
      6. Competitive Benchmarking
      7. Leading Players in Terms of Number of Developments
      8. in the Drug of Abuse Testing Market
      9. Key developments and growth strategies
        1. New Product Launch/Service Deployment
        2. Merger & Acquisitions
        3. Joint Ventures
      10. Major Players Financial Matrix
        1. Major Players R&D Expenditure. 2023
      11. 11.8.1.
      12. Sales and Operating Income
    14. COMPANY PROFILES
      1. F. HoffmannLa Roche
        1. Financial
        2. Products Offered
        3. Key Developments
        4. Key Strategies
      2. Overview
      3. 12.1.4.
      4. SWOT Analysis
      5. Sonic Healthcare
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      6. 12.2.1.
      7. Financial Overview
      8. Quest Diagnostics
        1. Financial Overview
        2. Products Offered
        3. Key
        4. SWOT Analysis
        5. Key Strategies
        6. Financial Overview
        7. Products
        8. Key Developments
        9. SWOT Analysis
      9. Developments
      10. 12.4.
      11. Thermo Fisher Scientific
      12. Offered
      13. 12.4.5.
      14. Key Strategies
      15. Henkel AG & Co KGaA
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
        5. Key Strategies
      16. Analysis
      17. Siemens Healthineers
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      18. 12.6.1.
      19. Financial Overview
      20. Dragerwerk
        1. Financial Overview
        2. Products Offered
        3. SWOT Analysis
        4. Key Strategies
        5. Financial Overview
        6. Key Developments
        7. SWOT Analysis
        8. Key Strategies
      21. AG
      22. 12.7.3.
      23. Key Developments
      24. 12.8.
      25. Laboratory Corporation of America
      26. 12.8.2.
      27. Products Offered
      28. Psychiatric Solutions
        1. Financial
        2. Products Offered
        3. Key Developments
        4. Key Strategies
      29. Overview
      30. 12.9.4.
      31. SWOT Analysis
      32. RCM Life Sciences
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      33. 12.10.1.
      34. Financial Overview
      35. NMS Labs
        1. Financial Overview
        2. Products Offered
        3. SWOT Analysis
        4. Key Strategies
      36. 12.11.3.
      37. Key Developments
      38. BD (Becton, Dickinson and Company)
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
        5. Key Strategies
      39. Analysis
      40. Alere Inc
        1. Financial
        2. Products Offered
        3. Key Developments
        4. Key Strategies
      41. Overview
      42. 12.13.4.
      43. SWOT Analysis
      44. Abbott Laboratories
        1. Financial Overview
        2. Products Offered
        3. Key
        4. SWOT Analysis
        5. Key Strategies
      45. Developments
      46. 13.
      47. APPENDIX
      48. References
      49. Related Reports
    15. LIST OF TABLES
      1. \r\nTABLE
    16. LIST OF ASSUMPTIONS
    17. NORTH AMERICA DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
      2. TABLE
    18. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY
      1. METHODOLOGY, 2019-2035 (USD BILLIONS)
    19. NORTH AMERICA DRUG OF ABUSE
    20. TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    21. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    22. NORTH AMERICA DRUG
    23. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD
      1. BILLIONS)
    24. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY TEST TYPE, 2019-2035 (USD BILLIONS)
    25. US DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE
    26. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    27. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    28. US DRUG
    29. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD
      1. BILLIONS)
    30. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    31. CANADA DRUG OF
    32. ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD
      1. BILLIONS)
    33. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    34. CANADA DRUG OF ABUSE
    35. TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD
      1. BILLIONS)
    36. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    37. EUROPE DRUG OF ABUSE
    38. TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    39. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    40. EUROPE DRUG OF ABUSE TESTING
    41. MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
      1. TABLE
    42. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE
      1. TESTED, 2019-2035 (USD BILLIONS)
    43. EUROPE DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
      2. TABLE
    44. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST
      1. TYPE, 2019-2035 (USD BILLIONS)
    45. GERMANY DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE
    46. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE,
    47. GERMANY DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
      2. TABLE
    48. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    49. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    50. UK DRUG OF
    51. ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD
      1. BILLIONS)
    52. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY END USE, 2019-2035 (USD BILLIONS)
    53. UK DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    54. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    55. FRANCE DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
      2. TABLE 33.
    56. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY,
    57. FRANCE DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    58. FRANCE
    59. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED,
    60. FRANCE DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
      2. TABLE 37.
    61. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE,
    62. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE 39.
    63. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    64. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    65. RUSSIA
    66. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    67. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    68. ITALY DRUG
    69. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    70. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    71. ITALY DRUG
    72. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    73. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    74. SPAIN DRUG
    75. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD
      1. BILLIONS)
    76. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    77. SPAIN DRUG OF
    78. ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    79. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    80. SPAIN DRUG OF ABUSE
    81. TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    82. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    83. REST OF EUROPE
    84. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    85. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    86. REST
    87. OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE
      1. TESTED, 2019-2035 (USD BILLIONS)
    88. REST OF EUROPE DRUG OF ABUSE TESTING
    89. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    90. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY
      1. TEST TYPE, 2019-2035 (USD BILLIONS)
    91. APAC DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE
    92. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE,
    93. APAC DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
      2. TABLE
    94. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    95. CHINA DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
      2. TABLE 63.
    96. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY,
    97. CHINA DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    98. CHINA
    99. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED,
    100. CHINA DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
      2. TABLE 67.
    101. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE,
    102. INDIA DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE 69.
    103. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    104. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    105. INDIA
    106. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    107. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    108. JAPAN DRUG
    109. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    110. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    111. JAPAN DRUG
    112. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    113. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    114. SOUTH KOREA
    115. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035
      1. (USD BILLIONS)
    116. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    117. SOUTH KOREA
    118. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    119. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    120. SOUTH
    121. KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    122. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    123. MALAYSIA
    124. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    125. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    126. MALAYSIA DRUG
    127. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    128. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    129. THAILAND DRUG
    130. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD
      1. BILLIONS)
    131. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    132. THAILAND DRUG
    133. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD
      1. BILLIONS)
    134. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    135. THAILAND
    136. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    137. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    138. INDONESIA
    139. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    140. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    141. INDONESIA DRUG
    142. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    143. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    144. REST OF APAC
    145. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035
      1. (USD BILLIONS)
    146. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    147. REST OF
    148. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    149. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    150. REST
    151. OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    152. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
      2. TABLE
    153. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY
      1. METHODOLOGY, 2019-2035 (USD BILLIONS)
    154. SOUTH AMERICA DRUG OF ABUSE
    155. TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    156. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    157. SOUTH AMERICA
    158. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    159. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    160. BRAZIL DRUG
    161. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    162. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    163. BRAZIL DRUG
    164. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    165. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    166. MEXICO DRUG
    167. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD
      1. BILLIONS)
    168. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    169. MEXICO DRUG
    170. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD
      1. BILLIONS)
    171. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    172. MEXICO
    173. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    174. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    175. ARGENTINA
    176. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    177. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    178. ARGENTINA
    179. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED,
    180. ARGENTINA DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
      2. TABLE
    181. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY TEST TYPE, 2019-2035 (USD BILLIONS)
    182. REST OF SOUTH AMERICA DRUG
    183. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    184. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
      2. TABLE
    185. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    186. REST OF SOUTH AMERICA
    187. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
      1. (USD BILLIONS)
    188. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
    189. MEA DRUG
    190. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035
      1. (USD BILLIONS)
    191. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    192. MEA DRUG OF
    193. ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035
      1. (USD BILLIONS)
    194. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    195. GCC COUNTRIES
    196. DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035
      1. (USD BILLIONS)
    197. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE
      1. ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
      2. TABLE 134.
    198. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END
      1. USE, 2019-2035 (USD BILLIONS)
    199. GCC COUNTRIES DRUG OF ABUSE TESTING
    200. MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    201. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES &
      1. FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    202. SOUTH AFRICA DRUG
    203. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD
      1. BILLIONS)
    204. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
    205. SOUTH
    206. AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035
      1. (USD BILLIONS)
    207. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES
      1. & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    208. SOUTH
    209. AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    210. REST OF MEA DRUG OF ABUSE TESTING MARKET
      1. SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
      2. TABLE
    211. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY
      1. METHODOLOGY, 2019-2035 (USD BILLIONS)
    212. REST OF MEA DRUG OF ABUSE
    213. TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
    214. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST,
      1. BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
    215. REST OF MEA DRUG
    216. OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD
      1. BILLIONS)
    217. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
      1. TABLE
    218. ACQUISITION/PARTNERSHIP
      1. \r\n
      2. \r\n
      3. \r\n
      4. \r\n
      5. \r\n
      6. \r\n
      7. \r\n
      8. \r\n
      9. \r\n
      10. \r\n
      11. \r\n
      12. \r\n
      13. \r\n
      14. \r\n
      15. \r\nLIST
    219. OF FIGURES
      1. \r\nFIGURE 1. MARKET SYNOPSIS
    220. NORTH AMERICA DRUG
    221. OF ABUSE TESTING MARKET ANALYSIS
    222. US DRUG OF ABUSE TESTING MARKET
      1. ANALYSIS BY TEST TYPE
    223. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY
      1. METHODOLOGY
    224. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    225. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    226. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE 8.
      2. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    227. CANADA
    228. DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    229. CANADA DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY END USE
    230. CANADA DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    231. CANADA DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY REGIONAL
    232. EUROPE DRUG OF ABUSE TESTING
    233. MARKET ANALYSIS
    234. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY
      1. TEST TYPE
    235. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    236. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    237. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      1. FIGURE
    238. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    239. UK
      1. DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    240. UK DRUG OF ABUSE
    241. TESTING MARKET ANALYSIS BY METHODOLOGY
    242. UK DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY END USE
    243. UK DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. BY SUBSTANCE TESTED
    244. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY
      1. REGIONAL
    245. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    246. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    247. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    248. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      1. FIGURE
    249. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    250. RUSSIA
      1. DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    251. RUSSIA DRUG
    252. OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    253. RUSSIA DRUG OF
      1. ABUSE TESTING MARKET ANALYSIS BY END USE
    254. RUSSIA DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY SUBSTANCE TESTED
    255. RUSSIA DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY REGIONAL
    256. ITALY DRUG OF ABUSE TESTING MARKET
      1. ANALYSIS BY TEST TYPE
    257. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS
    258. BY METHODOLOGY
    259. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY END
      1. USE
    260. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    261. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE
    262. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    263. SPAIN
    264. DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    265. SPAIN DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY END USE
    266. SPAIN DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    267. SPAIN DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY REGIONAL
    268. REST OF EUROPE DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY TEST TYPE
    269. REST OF EUROPE DRUG OF ABUSE
    270. TESTING MARKET ANALYSIS BY METHODOLOGY
    271. REST OF EUROPE DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY END USE
    272. REST OF EUROPE DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    273. REST OF EUROPE DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    274. APAC DRUG OF ABUSE
    275. TESTING MARKET ANALYSIS
    276. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. BY TEST TYPE
    277. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    278. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    279. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      1. FIGURE
    280. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    281. INDIA
      1. DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    282. INDIA DRUG OF
    283. ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    284. INDIA DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY END USE
    285. INDIA DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY SUBSTANCE TESTED
    286. INDIA DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY REGIONAL
    287. JAPAN DRUG OF ABUSE TESTING MARKET
      1. ANALYSIS BY TEST TYPE
    288. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS
    289. BY METHODOLOGY
    290. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY END
      1. USE
    291. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    292. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE
    293. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
      1. FIGURE
    294. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
      1. FIGURE
    295. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE 68.
      2. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      3. FIGURE
    296. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE 70.
      2. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    297. MALAYSIA
    298. DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    299. MALAYSIA DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY END USE
    300. MALAYSIA DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    301. MALAYSIA DRUG OF ABUSE
      1. TESTING MARKET ANALYSIS BY REGIONAL
    302. THAILAND DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY TEST TYPE
    303. THAILAND DRUG OF ABUSE TESTING MARKET
    304. ANALYSIS BY METHODOLOGY
    305. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. BY END USE
    306. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE
      1. TESTED
    307. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    308. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    309. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    310. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    311. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      1. FIGURE
    312. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE 85.
      2. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
      3. FIGURE 86.
    313. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
      1. FIGURE 87.
      2. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    314. REST
      1. OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      2. FIGURE 89.
      3. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      4. FIGURE 90.
    315. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS
    316. BRAZIL DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    317. BRAZIL DRUG OF ABUSE
    318. TESTING MARKET ANALYSIS BY METHODOLOGY
    319. BRAZIL DRUG OF ABUSE TESTING
      1. MARKET ANALYSIS BY END USE
    320. BRAZIL DRUG OF ABUSE TESTING MARKET
      1. ANALYSIS BY SUBSTANCE TESTED
    321. BRAZIL DRUG OF ABUSE TESTING MARKET
      1. ANALYSIS BY REGIONAL
    322. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. BY TEST TYPE
    323. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    324. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    325. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
      1. FIGURE
    326. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
      1. FIGURE 101.
      2. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    327. ARGENTINA
    328. DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    329. ARGENTINA
      1. DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    330. ARGENTINA DRUG
      1. OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    331. ARGENTINA
      1. DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    332. REST OF SOUTH
      1. AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    333. REST
    334. OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
      1. FIGURE
    335. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    336. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE
      1. TESTED
    337. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. BY REGIONAL
    338. MEA DRUG OF ABUSE TESTING MARKET ANALYSIS
      1. FIGURE
    339. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
      1. FIGURE
    340. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
      1. FIGURE
    341. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
      1. FIGURE
    342. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    343. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    344. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    345. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    346. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    347. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE
      1. TESTED
    348. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    349. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
    350. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
    351. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
    352. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
    353. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
    354. KEY BUYING CRITERIA OF DRUG OF ABUSE TESTING MARKET
      1. FIGURE
    355. RESEARCH PROCESS OF MRFR
    356. DRO ANALYSIS OF DRUG OF ABUSE TESTING
      1. MARKET
    357. DRIVERS IMPACT ANALYSIS: DRUG OF ABUSE TESTING MARKET
    358. RESTRAINTS IMPACT ANALYSIS: DRUG OF ABUSE TESTING MARKET
      1. FIGURE
    359. SUPPLY / VALUE CHAIN: DRUG OF ABUSE TESTING MARKET
    360. DRUG OF
    361. ABUSE TESTING MARKET, BY TEST TYPE, 2025 (% SHARE)
    362. DRUG OF ABUSE
    363. TESTING MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
    364. DRUG
    365. OF ABUSE TESTING MARKET, BY METHODOLOGY, 2025 (% SHARE)
    366. DRUG OF
    367. ABUSE TESTING MARKET, BY METHODOLOGY, 2019 TO 2035 (USD Billions)
      1. FIGURE 137.
    368. DRUG OF ABUSE TESTING MARKET, BY END USE, 2025 (% SHARE)
    369. DRUG
    370. OF ABUSE TESTING MARKET, BY END USE, 2019 TO 2035 (USD Billions)
      1. FIGURE 139.
    371. DRUG OF ABUSE TESTING MARKET, BY SUBSTANCE TESTED, 2025 (% SHARE)
      1. FIGURE 140.
    372. DRUG OF ABUSE TESTING MARKET, BY SUBSTANCE TESTED, 2019 TO 2035 (USD Billions)
    373. DRUG OF ABUSE TESTING MARKET, BY REGIONAL, 2025 (% SHARE)
      1. FIGURE
    374. DRUG OF ABUSE TESTING MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
    375. BENCHMARKING OF MAJOR COMPETITORS
      1. \r\n

    Drug of Abuse Testing Market Segmentation

    • Drug of Abuse Testing Market By Test Type (USD Billion, 2019-2035)
      • Urine Testing
      • Blood Testing
      • Saliva Testing
      • Hair Testing

     

    • Drug of Abuse Testing Market By Methodology (USD Billion, 2019-2035)
      • Immunoassays
      • Chromatography
      • Spectrometry

     

    • Drug of Abuse Testing Market By End Use (USD Billion, 2019-2035)
      • Hospitals
      • Laboratories
      • Workplaces
      • Home Care

     

    • Drug of Abuse Testing Market By Substance Tested (USD Billion, 2019-2035)
      • Cannabis
      • Cocaine
      • Opiates
      • Amphetamines
      • Phencyclidine

     

    • Drug of Abuse Testing Market By Regional (USD Billion, 2019-2035)
      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa

     

    Drug of Abuse Testing Market Regional Outlook (USD Billion, 2019-2035)

     

     

    • North America Outlook (USD Billion, 2019-2035)
      • North America Drug of Abuse Testing Market by Test Type
        • Urine Testing
        • Blood Testing
        • Saliva Testing
        • Hair Testing
      • North America Drug of Abuse Testing Market by Methodology Type
        • Immunoassays
        • Chromatography
        • Spectrometry
      • North America Drug of Abuse Testing Market by End Use Type
        • Hospitals
        • Laboratories
        • Workplaces
        • Home Care
      • North America Drug of Abuse Testing Market by Substance Tested Type
        • Cannabis
        • Cocaine
        • Opiates
        • Amphetamines
        • Phencyclidine
      • North America Drug of Abuse Testing Market by Regional Type
        • US
        • Canada
      • US Outlook (USD Billion, 2019-2035)
      • US Drug of Abuse Testing Market by Test Type
        • Urine Testing
        • Blood Testing
        • Saliva Testing
        • Hair Testing
      • US Drug of Abuse Testing Market by Methodology Type
        • Immunoassays
        • Chromatography
        • Spectrometry
      • US Drug of Abuse Testing Market by End Use Type
        • Hospitals
        • Laboratories
        • Workplaces
        • Home Care
      • US Drug of Abuse Testing Market by Substance Tested Type
        • Cannabis
        • Cocaine
        • Opiates
        • Amphetamines
        • Phencyclidine
      • CANADA Outlook (USD Billion, 2019-2035)
      • CANADA Drug of Abuse Testing Market by Test Type
        • Urine Testing
        • Blood Testing
        • Saliva Testing
        • Hair Testing
      • CANADA Drug of Abuse Testing Market by Methodology Type
        • Immunoassays
        • Chromatography
        • Spectrometry
      • CANADA Drug of Abuse Testing Market by End Use Type
        • Hospitals
        • Laboratories
        • Workplaces
        • Home Care
      • CANADA Drug of Abuse Testing Market by Substance Tested Type
        • Cannabis
        • Cocaine
        • Opiates
        • Amphetamines
        • Phencyclidine
      • Europe Outlook (USD Billion, 2019-2035)
        • Europe Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • Europe Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • Europe Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • Europe Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • Europe Drug of Abuse Testing Market by Regional Type
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Spain
          • Rest of Europe
        • GERMANY Outlook (USD Billion, 2019-2035)
        • GERMANY Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • GERMANY Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • GERMANY Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • GERMANY Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • UK Outlook (USD Billion, 2019-2035)
        • UK Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • UK Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • UK Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • UK Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • FRANCE Outlook (USD Billion, 2019-2035)
        • FRANCE Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • FRANCE Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • FRANCE Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • FRANCE Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • RUSSIA Outlook (USD Billion, 2019-2035)
        • RUSSIA Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • RUSSIA Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • RUSSIA Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • RUSSIA Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • ITALY Outlook (USD Billion, 2019-2035)
        • ITALY Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • ITALY Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • ITALY Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • ITALY Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • SPAIN Outlook (USD Billion, 2019-2035)
        • SPAIN Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • SPAIN Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • SPAIN Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • SPAIN Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • REST OF EUROPE Outlook (USD Billion, 2019-2035)
        • REST OF EUROPE Drug of Abuse Testing Market by Test Type
          • Urine Testing
          • Blood Testing
          • Saliva Testing
          • Hair Testing
        • REST OF EUROPE Drug of Abuse Testing Market by Methodology Type
          • Immunoassays
          • Chromatography
          • Spectrometry
        • REST OF EUROPE Drug of Abuse Testing Market by End Use Type
          • Hospitals
          • Laboratories
          • Workplaces
          • Home Care
        • REST OF EUROPE Drug of Abuse Testing Market by Substance Tested Type
          • Cannabis
          • Cocaine
          • Opiates
          • Amphetamines
          • Phencyclidine
        • APAC Outlook (USD Billion, 2019-2035)
          • APAC Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • APAC Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • APAC Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • APAC Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • APAC Drug of Abuse Testing Market by Regional Type
            • China
            • India
            • Japan
            • South Korea
            • Malaysia
            • Thailand
            • Indonesia
            • Rest of APAC
          • CHINA Outlook (USD Billion, 2019-2035)
          • CHINA Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • CHINA Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • CHINA Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • CHINA Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • INDIA Outlook (USD Billion, 2019-2035)
          • INDIA Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • INDIA Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • INDIA Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • INDIA Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • JAPAN Outlook (USD Billion, 2019-2035)
          • JAPAN Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • JAPAN Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • JAPAN Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • JAPAN Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • SOUTH KOREA Outlook (USD Billion, 2019-2035)
          • SOUTH KOREA Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • SOUTH KOREA Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • SOUTH KOREA Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • SOUTH KOREA Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • MALAYSIA Outlook (USD Billion, 2019-2035)
          • MALAYSIA Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • MALAYSIA Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • MALAYSIA Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • MALAYSIA Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • THAILAND Outlook (USD Billion, 2019-2035)
          • THAILAND Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • THAILAND Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • THAILAND Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • THAILAND Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • INDONESIA Outlook (USD Billion, 2019-2035)
          • INDONESIA Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • INDONESIA Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • INDONESIA Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • INDONESIA Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • REST OF APAC Outlook (USD Billion, 2019-2035)
          • REST OF APAC Drug of Abuse Testing Market by Test Type
            • Urine Testing
            • Blood Testing
            • Saliva Testing
            • Hair Testing
          • REST OF APAC Drug of Abuse Testing Market by Methodology Type
            • Immunoassays
            • Chromatography
            • Spectrometry
          • REST OF APAC Drug of Abuse Testing Market by End Use Type
            • Hospitals
            • Laboratories
            • Workplaces
            • Home Care
          • REST OF APAC Drug of Abuse Testing Market by Substance Tested Type
            • Cannabis
            • Cocaine
            • Opiates
            • Amphetamines
            • Phencyclidine
          • South America Outlook (USD Billion, 2019-2035)
            • South America Drug of Abuse Testing Market by Test Type
              • Urine Testing
              • Blood Testing
              • Saliva Testing
              • Hair Testing
            • South America Drug of Abuse Testing Market by Methodology Type
              • Immunoassays
              • Chromatography
              • Spectrometry
            • South America Drug of Abuse Testing Market by End Use Type
              • Hospitals
              • Laboratories
              • Workplaces
              • Home Care
            • South America Drug of Abuse Testing Market by Substance Tested Type
              • Cannabis
              • Cocaine
              • Opiates
              • Amphetamines
              • Phencyclidine
            • South America Drug of Abuse Testing Market by Regional Type
              • Brazil
              • Mexico
              • Argentina
              • Rest of South America
            • BRAZIL Outlook (USD Billion, 2019-2035)
            • BRAZIL Drug of Abuse Testing Market by Test Type
              • Urine Testing
              • Blood Testing
              • Saliva Testing
              • Hair Testing
            • BRAZIL Drug of Abuse Testing Market by Methodology Type
              • Immunoassays
              • Chromatography
              • Spectrometry
            • BRAZIL Drug of Abuse Testing Market by End Use Type
              • Hospitals
              • Laboratories
              • Workplaces
              • Home Care
            • BRAZIL Drug of Abuse Testing Market by Substance Tested Type
              • Cannabis
              • Cocaine
              • Opiates
              • Amphetamines
              • Phencyclidine
            • MEXICO Outlook (USD Billion, 2019-2035)
            • MEXICO Drug of Abuse Testing Market by Test Type
              • Urine Testing
              • Blood Testing
              • Saliva Testing
              • Hair Testing
            • MEXICO Drug of Abuse Testing Market by Methodology Type
              • Immunoassays
              • Chromatography
              • Spectrometry
            • MEXICO Drug of Abuse Testing Market by End Use Type
              • Hospitals
              • Laboratories
              • Workplaces
              • Home Care
            • MEXICO Drug of Abuse Testing Market by Substance Tested Type
              • Cannabis
              • Cocaine
              • Opiates
              • Amphetamines
              • Phencyclidine
            • ARGENTINA Outlook (USD Billion, 2019-2035)
            • ARGENTINA Drug of Abuse Testing Market by Test Type
              • Urine Testing
              • Blood Testing
              • Saliva Testing
              • Hair Testing
            • ARGENTINA Drug of Abuse Testing Market by Methodology Type
              • Immunoassays
              • Chromatography
              • Spectrometry
            • ARGENTINA Drug of Abuse Testing Market by End Use Type
              • Hospitals
              • Laboratories
              • Workplaces
              • Home Care
            • ARGENTINA Drug of Abuse Testing Market by Substance Tested Type
              • Cannabis
              • Cocaine
              • Opiates
              • Amphetamines
              • Phencyclidine
            • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
            • REST OF SOUTH AMERICA Drug of Abuse Testing Market by Test Type
              • Urine Testing
              • Blood Testing
              • Saliva Testing
              • Hair Testing
            • REST OF SOUTH AMERICA Drug of Abuse Testing Market by Methodology Type
              • Immunoassays
              • Chromatography
              • Spectrometry
            • REST OF SOUTH AMERICA Drug of Abuse Testing Market by End Use Type
              • Hospitals
              • Laboratories
              • Workplaces
              • Home Care
            • REST OF SOUTH AMERICA Drug of Abuse Testing Market by Substance Tested Type
              • Cannabis
              • Cocaine
              • Opiates
              • Amphetamines
              • Phencyclidine
            • MEA Outlook (USD Billion, 2019-2035)
              • MEA Drug of Abuse Testing Market by Test Type
                • Urine Testing
                • Blood Testing
                • Saliva Testing
                • Hair Testing
              • MEA Drug of Abuse Testing Market by Methodology Type
                • Immunoassays
                • Chromatography
                • Spectrometry
              • MEA Drug of Abuse Testing Market by End Use Type
                • Hospitals
                • Laboratories
                • Workplaces
                • Home Care
              • MEA Drug of Abuse Testing Market by Substance Tested Type
                • Cannabis
                • Cocaine
                • Opiates
                • Amphetamines
                • Phencyclidine
              • MEA Drug of Abuse Testing Market by Regional Type
                • GCC Countries
                • South Africa
                • Rest of MEA
              • GCC COUNTRIES Outlook (USD Billion, 2019-2035)
              • GCC COUNTRIES Drug of Abuse Testing Market by Test Type
                • Urine Testing
                • Blood Testing
                • Saliva Testing
                • Hair Testing
              • GCC COUNTRIES Drug of Abuse Testing Market by Methodology Type
                • Immunoassays
                • Chromatography
                • Spectrometry
              • GCC COUNTRIES Drug of Abuse Testing Market by End Use Type
                • Hospitals
                • Laboratories
                • Workplaces
                • Home Care
              • GCC COUNTRIES Drug of Abuse Testing Market by Substance Tested Type
                • Cannabis
                • Cocaine
                • Opiates
                • Amphetamines
                • Phencyclidine
              • SOUTH AFRICA Outlook (USD Billion, 2019-2035)
              • SOUTH AFRICA Drug of Abuse Testing Market by Test Type
                • Urine Testing
                • Blood Testing
                • Saliva Testing
                • Hair Testing
              • SOUTH AFRICA Drug of Abuse Testing Market by Methodology Type
                • Immunoassays
                • Chromatography
                • Spectrometry
              • SOUTH AFRICA Drug of Abuse Testing Market by End Use Type
                • Hospitals
                • Laboratories
                • Workplaces
                • Home Care
              • SOUTH AFRICA Drug of Abuse Testing Market by Substance Tested Type
                • Cannabis
                • Cocaine
                • Opiates
                • Amphetamines
                • Phencyclidine
              • REST OF MEA Outlook (USD Billion, 2019-2035)
              • REST OF MEA Drug of Abuse Testing Market by Test Type
                • Urine Testing
                • Blood Testing
                • Saliva Testing
                • Hair Testing
              • REST OF MEA Drug of Abuse Testing Market by Methodology Type
                • Immunoassays
                • Chromatography
                • Spectrometry
              • REST OF MEA Drug of Abuse Testing Market by End Use Type
                • Hospitals
                • Laboratories
                • Workplaces
                • Home Care
              • REST OF MEA Drug of Abuse Testing Market by Substance Tested Type
                • Cannabis
                • Cocaine
                • Opiates
                • Amphetamines
                • Phencyclidine

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions